Form 4 for ENVB Enveric Biosciences, Inc.
Accepted 2023-01-27 00:00:00 ET · period of report 2023-01-25 · accession 0001493152-23-002800 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-27 | 2023-01-25 | ENVB | Kanubaddi Avani | Pres, COO | A - Grant | $0.00 | +10.0K | 48.3K | +26% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-25 | A | A | 10,000 | $0.00 | 48,346 | D | — | — | (F1) Represents the restricted stock units (the "RSUs") granted to the reporting person pursuant to the Enveric Biosciences, Inc. (the "Company") 2020 Long-Term Incentive Plan. For each vested restricted stock unit, the reporting person will be entitled to receive one share of common stock. The RSUs vest in four equal annual installments, with the first installment vesting upon the one year anniversary of the date of issuance. (F2) Includes 38,346 restricted stock units previously reported on Table II. |